Log in to save to my catalogue

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1080_22221751_2020_1823890

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

About this item

Full title

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

Publisher

United States: Taylor & Francis

Journal title

Emerging microbes & infections, 2020-01, Vol.9 (1), p.2091-2093

Language

English

Formats

Publication information

Publisher

United States: Taylor & Francis

More information

Scope and Contents

Contents

We studied plasma antibody responses of 35 patients about 1 month after SARS-CoV-2 infection. Titers of antibodies binding to the viral nucleocapsid and spike proteins were significantly higher in patients with severe disease. Likewise, mean antibody neutralization titers against SARS-CoV-2 pseudovirus and live virus were higher in the sicker patie...

Alternative Titles

Full title

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1080_22221751_2020_1823890

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1080_22221751_2020_1823890

Other Identifiers

ISSN

2222-1751

E-ISSN

2222-1751

DOI

10.1080/22221751.2020.1823890

How to access this item